Tenderwize
Wróć do wyszukiwania

Pharmaceutical discount agreements open-house procedure

IKK classic·Dresden, Germany·Deadline Jan 05, 2028 · 496 days left·Open·Supplies
Zarejestruj się, aby zapisaćOpen documents
Structured notice only
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-Verfahren

50/100

Ocena szansy

Needs reviewLow complexity
SuppliesOpen
Skąd ta ocena?

Szansa

50 / 100

Złożoność

20 / 100

Czynniki ryzyka

No estimated value or volume commitment; actual revenue is uncertain and dependent on market conditions.

The agreement may be terminated if exclusive discount agreements for the same active ingredients come into effect durin...

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Supplies contract
  • 2 lots
  • Duration until Feb 2028
  • Non-exclusive discount agreements for pharmaceutical products (Dronabinol and medical cannabis extract) under §130a SGB V.
  • Open-house procedure allowing continuous enrollment from March 2026 to February 2028.
Pokaż pełne podsumowanie

The IKK classic health insurance fund announces non-exclusive discount agreements (Rabattverträge) for pharmaceutical products under §130a SGB V via an open-house procedure for two lots: Dronabinol and medical cannabis extract. The procedure allows continuous enrollment from March 2026 to February 2028. No estimated values are provided. Submission is via email or postal mail; electronic submission is not supported. Eligibility is restricted to pharmaceutical entrepreneurs per §4 Abs. 18 AMG.

Ryzyka

No estimated value or volume commitment; actual revenue is uncertain and dependent on market conditions.

The agreement may be terminated if exclusive discount agreements for the same active ingredients come into effect durin...

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • Must be a pharmaceutical entrepreneur per §4 Abs. 18 AMG.

Administrative

  • Submit signed contract, all necessary evidence, self-declarations, and trade register extract (not older than 6 months at contract start).
  • Submission via email to [email protected] or by postal mail; electronic submission not allowed.

Wymagania mogą być niepełne.

Kryteria udzielenia

Lot 1

No award criteria specified; participation is based on fulfilling non-negotiable terms.

Lot 2

No award criteria specified; participation is based on fulfilling non-negotiable terms.

Zamawiający

Lokalizacja

Dresden, DEU

Identyfikator

993-80175-34

Działalność

Health

Części (2)

LOT-0001

Dronabinol (Active Ingredient)

Non-exclusive discount agreement for the active ingredient Dronabinol, all dosage forms and package sizes. Contract duration from March 2026 to February 2028, with possible extension by up to 12 months at IKK classic's discretion.

SuppliesEU fundedElectronic submission

Lokalizacja

DED21, Germany

Czas trwania

Feb 2026 - Feb 2028

Kategoria

Pharmaceutical products

Kryteria udzielenia

No award criteria specified; participation is based on fulfilling non-negotiable terms.

Termin

Deadline Jan 05, 2028

LOT-0002

Medical Cannabis Extract

Non-exclusive discount agreement for medical cannabis extract in various forms (LOE/EXTR/OEL/SUB), all THC/CBD strengths and package sizes. Contract duration from March 2026 to February 2028, with possible extension by up to 12 months.

SuppliesEU fundedElectronic submission

Lokalizacja

DED21, Germany

Czas trwania

Feb 2026 - Feb 2028

Kategoria

Pharmaceutical products

Kryteria udzielenia

No award criteria specified; participation is based on fulfilling non-negotiable terms.

Termin

Deadline Jan 05, 2028

Szczegóły zamówienia

Data publikacji
18 Jan 2026
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
36907-2026

Dokumenty (1)

Dokument zamówienia 1

Podobne przetargi

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3